Viewing Study NCT00942305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-05-12 @ 9:57 PM
Study NCT ID: NCT00942305
Status: COMPLETED
Last Update Posted: 2021-07-16
First Post: 2009-07-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients
Sponsor: Jazz Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cytomegalovirus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Allogeneic stem cell transplant View
None CMV seropositive (R+) View
None transplant View